Stay updated on Entrectinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedCholangiocarcinoma has been removed from the study's listed conditions, affecting the diseases covered by this basket trial. A new Revision: v3.6.4 was added, and some related topics and an older revision reference were removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.6.3 has been added, replacing the previous Revision: v3.6.0. This update reflects a newer underlying software version powering the page.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page now indicates the study is no longer recruiting and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study); it also updates the header formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and includes a site revision tag (Revision: v3.6.0).SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays the latest Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor build update.SummaryDifference0.0%

- Check56 days agoChange DetectedNew date values were added (e.g., 2026-05-27 and 2027-06-30) and old dates (e.g., 2026-03-06, 2026-05-14, 2026-03-05, 2026-03) were removed, reflecting updates to the study timeline and last-updated timestamps on the record.SummaryDifference0.1%

- Check71 days agoChange DetectedPublications section gained a new citation for a comparative effectiveness analysis of entrectinib and crizotinib in ROS1+ NSCLC. The Erratum reference for that publication was removed and the page revision tag updated to v3.5.4.SummaryDifference0.0%

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.